|
BEE VENOM COMPOSITION +
List of substances
and their properties
Bee venom is a combination of many useful components.
Modern biochemical analytical procedures have been used to
identify 18 different components. The major components of bee
venom include the following:
| PEPTIDES |
melittin (family)
melittin F
apamin
mast-cell degranulation peptide 401 (MCD)
secarpin
tertiapin
adolapin
protease inhibitor
procamine A, B
minimine
cardiopep |
| ENZYMES |
phospholipase A2
hyaluronidase
acid phosphomonoesterase
glucosidase
lysophospholipase |
|
ACTIVE AMINES |
histamine
dopamine
norepinephrine
leukotriens |
|
NON-PEPTIDE COMPONENTS
|
carbohydrates like:
Glucose
Fructose |
|
LIPIDS
|
6 phospholipids |
|
AMINO-ACIDS
|
r-aminobutyric acid
B-aminoisobutyric acid |
Dr. Kim M-H. Christopher, one of the world's best expert in
bee venom therapy, has published in Bee Informed, Journal of
the American Apitherapy Society (autumn issue, 1997), the following
table related to the dried bee venom composition:
|
COMPONENT |
MOL. Wt. |
% (Dry Venom) |
Reference |
|
PEPTIDES |
|
|
|
|
Melittin |
2,840 |
40-50 |
Neumann et al., 1952 |
|
Apamin |
2,036 |
2-3 |
Habermann et al., 1965 |
|
MCD-Peptide 401 |
2,588 |
2-3 |
Fredholm, 1966 |
|
Adolapin |
11,500 |
1.0 |
Shkenderov, 1982 |
|
Protease inhibitor |
9,000 |
< 0.8 |
Shkenderov, 1973 |
|
Secarpin |
|
0.5 |
Gauldie et al, 1976 |
|
Tertiapin |
|
0.1 |
Gauldie et al, 1976 |
|
Melittin F |
|
0.01 |
Gauldie et al, 1976 |
|
Procamine A, B |
|
1.4 |
Nelson and O’Connor, 1968 |
|
Minimine |
6,000 |
2-3 |
Lowy et al, 1971 |
|
Cardiopep |
|
< 0.7 |
Vick et al, 1974 |
|
|
|
|
|
|
ENZYMES |
|
|
|
|
Hyaluronidase |
38,000 |
1.5-2.0 |
Neumann & Habermann |
|
Phospholipase A2 |
19,000 |
10-12 |
Habermann & Neumann, 1957 |
|
Glucosidase |
170,000 |
0.6 |
Shkenderov et al, 1979 |
|
Acid Phosphomono-esterase |
55,000 |
1.0 |
Shkenderov et al, 1979 |
|
Lysophospholipase |
22,000 |
1.0 |
Ivanova et al, 1982 |
|
|
|
|
|
|
ACTIVE AMINES |
|
|
|
|
Histamine |
|
|
|
|
Dopamine |
|
0.13-1.0 |
Owen, 171 |
|
Norepinephrine |
|
0.1-0.7 |
Owen, 1982 |
|
|
|
|
|
|
NON-PEPTIDE COMPONENTS |
|
|
|
|
Carbohydrates: Glucose & Fructose |
|
< 2.0 |
O’Connor et al, 1967 |
|
|
|
|
|
|
LIPIDS |
|
|
|
|
6 Phospholipids |
|
4.5 |
O’Connor et al, 1967 |
|
|
|
|
|
|
AMINO-ACIDS |
|
|
|
|
r-Aminobutyric acid |
|
< 0.5 |
Nelson & O’Connor, 1968 |
|
B-Aminoisobutyric acid |
|
< 0.01 |
Nelson & O’Connor, 1968 |
B.V. SUBSTANCES AND THEIR EFFECTS:
| Phospholipase A (enzyme) |
-
radioprotective activity;
-
mastocytolitic;
-
histamine release;
-
blood pressure depressants
-
antigenic properties;
it is the major BV allergen ;
-
antagonistic effect on staphylococic
alfa-toxin and tetanus toxin;
-
antitumoural effect
-
acts on biological membranes
|
|
Hyaluronidase |
-
selectively attacks tissue hyaluronic
acid polymers;
-
increase the capillary permeability
(Neumann and Habermann);
-
immune response and tissue-spread
properties;
-
antigenic;
-
anaphylactogene
|
|
Apamin (a polypeptide with 18 amino acids) |
|
| Melittin (a polypeptide
also consisting of 26 amino acids which represents 40-60%
of the bee venom) |
- antibacterial;
- antifungal;
- anti-lyme disease (in vitro experiment)
- antitumoural;
- central nervous system inhibitory;
- block nerve muscle and ganglial synapses;
- contraction of the striated and smooth muscles;
- histamine releasing;
- mastocytololysic;
- radio protecting (against X-irradiation; study
on mice, Shipman and Cole, 1967);
- vascular permeability increasing;
- haemolysis;
- lowers blood pressure;
- anti-inflammatory;
- mellitin (which represents 40-60 % from the B.V.
substances) has no antigenic properties (Orlov);
otherwise, according to Artemov, the bee enemies
would have gotten a specific immunity;
- stimulate the pituitary - adrenal axis to release
both cathecolamines and cortisol (Brooks et al.);
- increase plasma cortisol levels
- acts on biological membranes
Presently, it is one of the most potent
anti-inflammatory agents known, and it can be useful
in treating arthritis and rheumatism. |
|
Mast Cell Degranulating peptide
|
In many animal studies,
in comparison studies with hydrocortisone, this peptide
was 100 times more potent as an anti-inflammatory
agent in suppressing the development of adjuvant-induced
arthritis. (Simics p 13) & quot. |
| Cardiopep |
-
increase both the force of contraction
(beta-adrenergic) and
the heart rate with little or no effect on coronary
circulation (Brooks et al.);
-
anti-arrhythmic properties (Brooks
et al.);
-
stimulate the pituitary - adrenal
axis to release both cathecolamines and cortisol
(Brooks et al.)
|
|
-
analgesic (Shkenderov, 1982);
-
anti-inflammatory (Shkenderov, 1982)
|
|
|